Early research (Phase 1)Study completedNCT06224608
What this trial is testing
Phase I Clinical Trial to Evaluate the Safety of Recombinant Mycobacterium Tuberculosis Fusion Protein (EEC) in Healthy Adults Aged 18-65 and Patients With Pulmonary Tuberculosis
Who this might be right for
Tuberculosis
Chengdu CoenBiotech Co., Ltd 60